trimethoprim--sulfamethoxazole-drug-combination has been researched along with Viremia* in 4 studies
4 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Viremia
| Article | Year |
|---|---|
Disseminated toxoplasmosis in a heart transplant patient despite co-trimoxazole prophylaxis: A case report.
We report the case of a 61 year-old male who underwent heart transplantation eight months before developing a systemic condition with central nervous system, lung, kidney, colonic, cutaneous, and hematologic involvement, found to be secondary to a systemic toxoplasmosis despite co-trimoxazole prophylaxis in a previous-to-transplant seronegative patient receiving a heart from a seropositive donor. A review of prophylactic options in our environment is discussed. Topics: Antibodies, Protozoan; Antiviral Agents; Combined Modality Therapy; Cytomegalovirus Infections; Disease Progression; Heart Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Postoperative Complications; Recurrence; Seroconversion; Tissue Donors; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Viremia | 2017 |
Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome.
Topics: Anti-Infective Agents; Child, Preschool; Drug Eruptions; Drug Therapy, Combination; Herpesvirus 6, Human; Humans; Hypersensitivity, Delayed; Low Back Pain; Male; Patch Tests; Rifampin; Roseolovirus Infections; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Viremia | 2011 |
Infectious toxicity using alemtuzumab.
Topics: 2-Aminopurine; Alemtuzumab; Antibiotic Prophylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; Bone Marrow Transplantation; CD52 Antigen; Clinical Trials as Topic; Cytomegalovirus Infections; Disease Susceptibility; Famciclovir; Ganciclovir; Glycoproteins; Graft vs Host Disease; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Incidence; Infections; Lymphoproliferative Disorders; Opportunistic Infections; Pneumonia, Pneumocystis; Rituximab; Transplantation Conditioning; Trimethoprim, Sulfamethoxazole Drug Combination; Viremia; Virus Activation | 2004 |
[Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-CD8 Ratio; Depression; Didanosine; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Mononucleosis; Male; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Treatment Refusal; Trimethoprim, Sulfamethoxazole Drug Combination; Viral Load; Viremia; Zalcitabine; Zidovudine | 2002 |